Neoadjuvant chemotherapy and chemotherapy cycle number: A national multicentre study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant chemotherapy and chemotherapy cycle number: A national multicentre study

Published:2017-11 Issue:2 Volume:147 Page:257-261
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Altman Alon D.,McGee Jacob,May Taymaa,Lane Kelly,Lu Lin,Xu Wei,Ghatage Prafull,Rosen Barry

Funder

Canadian Partnership against Cancer (CPAC)

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference36 articles.

1. Consolidation therapy in ovarian cancer: where do we stand?;Dearnley;Curr. Opin. Obstet. Gynecol.,2006

2. Maintenance or consolidation therapy in advanced ovarian cancer;Pectasides;Oncology,2006

3. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a gynecologic oncology group study;Chan;Gynecol. Oncol.,2010

4. Is there a high-risk subgroup of stage I epithelial ovarian cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy?;Bakkum-Gamez;Int. J. Gynecol. Cancer,2010

5. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a gynecologic oncology group study;Bell;Gynecol. Oncol.,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations between Patient-Generated Subjective Global Assessment criteria and all-cause mortality among cancer patients: Evidence from baseline and longitudinal analyses;Nutrition;2024-11

2. Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer;Gynecologic and Obstetric Investigation;2024-06-05

3. Evaluation of short versus long course chemotherapy in the neoadjuvant setting in ovarian cancer;2024-02-13

4. Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinoma;International Journal of Gynecologic Cancer;2023-12-06

5. Current Status and Controversies in Neoadjuvant Chemotherapy for Advanced Stage Ovarian Cancer: A Review;Clinical and Experimental Obstetrics & Gynecology;2023-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3